| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human TACI/TNFRSF13B Fc Chimera Protein, CF |
|---|
| Description | Purity >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 51 kDa and 40 kDa, reducing conditions. MW (theoretical): 45.2 kDa (starts at Ser2, monomer)31.3 kDa (starts at Ser123, monomer). The Recombinant Human TACI/TNFRSF13B Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human TACI/TNFRSF13B Fc Chimera Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF13B, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B |
|---|
| Gene, Accession, CAS # | TNFRSF13B, Gene ID: 23495, Accession: Q53F36 |
|---|
| Catalog # | 174-TC-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human TACI/TNFRSF13B Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 15070697, 25247707 |
|---|
| 产品资料 |
|
|